EXJADE for Myelodysplastic syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 35 adverse event reports in the FDA FAERS database where EXJADE was used for Myelodysplastic syndrome.
Most Reported Side Effects for EXJADE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 39 | 12.3% | 39 | 2 |
| Diarrhoea | 30 | 9.4% | 1 | 12 |
| Abdominal pain | 15 | 4.7% | 2 | 9 |
| Vomiting | 15 | 4.7% | 1 | 6 |
| Abdominal pain upper | 14 | 4.4% | 0 | 6 |
| Malaise | 14 | 4.4% | 1 | 7 |
| Pneumonia | 14 | 4.4% | 3 | 8 |
| Pyrexia | 13 | 4.1% | 1 | 9 |
| Rash | 13 | 4.1% | 1 | 4 |
| Anaemia | 12 | 3.8% | 4 | 5 |
| Dyspnoea | 12 | 3.8% | 2 | 9 |
| Haemoglobin decreased | 12 | 3.8% | 3 | 8 |
| Nausea | 12 | 3.8% | 1 | 6 |
| Pain | 11 | 3.5% | 1 | 9 |
| Blood iron increased | 10 | 3.1% | 0 | 3 |
Other Indications for EXJADE
Iron overload (146)
Sickle cell anaemia (26)
Thalassaemia beta (24)
Haemochromatosis (16)
Thalassaemia (8)
Iron metabolism disorder (7)
Myelofibrosis (6)
Product used for unknown indication (6)
Haemosiderosis (5)
Other Drugs Used for Myelodysplastic syndrome
LENALIDOMIDE (14,132)
AZACITIDINE (5,741)
VENETOCLAX (2,508)
DEFERASIROX (1,445)
DARBEPOETIN ALFA (1,164)
RUXOLITINIB (886)
REVLIMID (835)
CEDAZURIDINE\DECITABINE (770)
LUSPATERCEPT-AAMT (609)
DECITABINE (429)